UFPT:NSD-UFP Technologies Inc (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 206.8

Change

-0.09 (-0.04)%

Market Cap

USD 1.62B

Volume

0.12M

Analyst Target

USD 50.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company offers protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and custom protective case systems for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. The company serves the medical, aerospace and defense, industrial, and automotive markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-25 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

+0.88 (+1.24%)

USD 23.46B
PODD Insulet Corporation

+1.33 (+0.51%)

USD 17.22B
MASI Masimo Corporation

+1.11 (+0.68%)

USD 7.80B
BRKR Bruker Corporation

+0.10 (+0.26%)

USD 5.53B
IRTC iRhythm Technologies Inc

+1.21 (+1.15%)

USD 3.28B
PRCT Procept Biorobotics Corp

-0.07 (-0.13%)

USD 2.85B
TMDX TransMedics Group Inc

-0.68 (-0.72%)

USD 2.73B
QDEL Quidel Corporation

+0.31 (+1.12%)

USD 2.42B
LIVN LivaNova PLC

N/A

USD 1.95B
NVCR Novocure Ltd

-0.05 (-0.27%)

USD 1.81B

ETFs Containing UFPT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.42% 60% D- 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.42% 60% D- 39% F
Trailing 12 Months  
Capital Gain -3.02% 71% C- 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.02% 71% C- 49% F
Trailing 5 Years  
Capital Gain 375.18% 98% N/A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 375.18% 98% N/A 95% A
Average Annual (5 Year Horizon)  
Capital Gain 58.99% 85% B 90% A-
Dividend Return 58.99% 85% B 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.93% 80% B- 58% F
Risk Adjusted Return 190.71% 100% F 100% F
Market Capitalization 1.62B 91% A- 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.